Showing 261 - 280 results of 27,337 for search '(( 50 a decrease ) OR ( 5 ((((non decrease) OR (fold decrease))) OR (nn decrease)) ))', query time: 0.75s Refine Results
  1. 261
  2. 262
  3. 263
  4. 264
  5. 265

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…Similarly, BACE1, LAMP1 and LC3B-II/ LC3B-I were also increased in nimodipine-treated 5XFAD compared to nimodipine treated non-transgenic mice, indicating that nimodipine did not decrease the accumulation of these dystrophic neurite marker proteins. …”
  6. 266
  7. 267
  8. 268
  9. 269
  10. 270
  11. 271
  12. 272
  13. 273
  14. 274
  15. 275
  16. 276
  17. 277

    Table_1_Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.docx by Yun Ji (464484)

    Published 2022
    “…Here we describe two fully human mAbs, amubarvimab (BRII-196) and romlusevimab (BRII-198) that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein and effectively neutralize SARS-CoV-2 variants. …”
  18. 278

    Talin concentration at muscle attachment sites increases 5-fold during attachment maturation. by Sandra B. Lemke (6519788)

    Published 2019
    “…Note that the concentration increases about 2-fold from 20 h to 24 h APF and 5-fold to 30 h APF. …”
  19. 279
  20. 280

    Number of significantly significant (P < 0.05) differentially abundant (SSDA) proteins showing increased or decreased activity (fold change +/- 1.5-fold) relative to time 0 following storage at 9°C or 20°C of infective juveniles of <i>S</i>.... by Peter E. Lillis (12368582)

    Published 2022
    “…<p>Number of significantly significant (P < 0.05) differentially abundant (SSDA) proteins showing increased or decreased activity (fold change +/- 1.5-fold) relative to time 0 following storage at 9°C or 20°C of infective juveniles of <i>S</i>. …”